Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells.
Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells.
复制标题
DOI:
10.1016/j.crmeth.2022.100290
复制
发表时间:
2022-09-19
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
CRISPR systems have revolutionized biomedical research because they offer an unprecedented opportunity for genome editing. However, a bottleneck of applying CRISPR systems in human pluripotent stem cells (hPSCs) is how to deliver CRISPR effectors easily and efficiently. Here, we developed modified mRNA (modRNA)-based CRIPSR systems that utilized Cas9 and p53DD or a base editor (ABE8e) modRNA for the purposes of knocking out genes in hPSCs via simple lipid-based transfection. ABE8e modRNA was employed to disrupt the splice donor site, resulting in defective splicing of the target transcript and ultimately leading to gene knockout. Using our modRNA CRISPR systems, we achieved 73.3% ± 11.2% and 69.6 ± 3.8% knockout efficiency with Cas9 plus p53DD modRNA and ABE8e modRNA, respectively, which was significantly higher than the plasmid-based systems. In summary, we demonstrate that our non-integrating modRNA-based CRISPR methods hold great promise as more efficient and accessible techniques for genome editing of hPSCs. Transfection of hPSCs with Cas9 modRNA yielded 90% transfection efficiency Gene editing of hPSCs via Cas9/p53DD modRNA yielded up to 84% knockout efficiency Cas9/p53DD modRNA method was better than plasmid- and RNP-based methods ABE8e modRNA achieved 5-fold knockout efficiency relative to the plasmid ABE8e Robust and efficient methods for knocking out genes in stem cells are indispensable in understanding the function of a gene during stem cell differentiation. Plasmid-based CRISPR systems can be used to generate gene knockouts, but the efficiency is low, and plasmid DNA may integrate into the genome and thus compromise genome integrity. We sought to develop non-integrating and efficient modified mRNA (modRNA)-based CRISPR systems (Cas9 or base editor) that can be used to achieve robust gene knockouts in both human embryonic stem cells and induced pluripotent stem cells to circumvent the challenges faced by plasmid-based CRISPR systems. Haideri et al. develop non-integrating modRNA-based CRISPR systems for achieving robust and efficient gene knockouts in hPSCs. They further establish an ABE8e base editor modRNA protocol to disrupt the splice donor site. These non-integrating approaches can preserve genome integrity and significantly enhance knockout efficiency.